Artemis Hospitals
Pediatric oncology in India typically costs from AUD $13,416 to AUD $57,337. Final costs depend on the cancer type, drug protocols, and whether complex surgeries or transplants are required. Australian families often find chemotherapy and advanced treatments in India offer 60–80% savings compared to private healthcare costs in Australia.
Typical Pediatric Oncology Costs in India
Specialised pediatric units are primarily located in Delhi, Mumbai, and Chennai. These cities offer advanced facilities with survival rates that match international standards. Request a consultation with a specialist to get accurate pricing and a treatment plan for your child's specific diagnosis.
| India | Thailand | Turkey | |
| Transnasal resection of tumor | from AUD $9,180 | from AUD $21,184 | from AUD $11,298 |
| Tomotherapy | from AUD $7,344 | from AUD $42,368 | from AUD $16,947 |
| Stereotaxic radiosurgery | from AUD $7,344 | from AUD $14,123 | from AUD $6,355 |
| Radiotherapy | from AUD $4,096 | from AUD $7,767 | from AUD $5,649 |
| Enucleation of eye | from AUD $2,613 | from AUD $5,649 | from AUD $7,626 |
No hidden fees – just official clinic prices. Pay at the clinic for Pediatric Oncology treatment upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pediatric Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pediatric Oncology treatment journey.
Dr Shruti Kate was a consultant at Tata Memorial Hospital, India's premier cancer centre, where she specialised in treating pediatric solid tumours and blood cancers.
Dr. Girish Badarkhe is a hematology-oncologist at HCG Manavata Cancer Centre in Nashik. He specializes in leukemia, multiple myeloma, and bone marrow transplants. Dr. Badarkhe treats both adults and children with complex blood disorders. He holds a DM in Clinical Hematology from Medical College, Calcutta.
Dr Gaurav Kharya is a specialist in paediatric haematology and oncology at Artemis Hospitals. He is one of the few experts focusing on bone marrow transplants for children with aggressive solid tumours.
Leukaemia is the most common childhood cancer in India, representing 30–40% of cases. Specialist care for paediatric leukaemia is widely available. It offers treatments like CAR T-cell therapy and bone marrow transplants. JCI-accredited facilities provide international protocols, including immunotherapy and targeted chemotherapy for complex blood disorders.
Bookimed Expert Insight: India's paediatric oncology landscape shows a distinct trend. Top-tier clinics bundle diagnostics with treatment. For example, BLK Super Speciality Hospital was a regional pioneer for the CyberKnife VSI system. This system is specifically for paediatric brain tumours. Choosing centres with on-site NABL-accredited labs, like Manipal Hospitals, results in faster diagnostic turnarounds. This is vital for initiating intensive leukaemia protocols quickly.
Patient Consensus: Families note that choosing JCI-accredited hospitals means protocols match international standards. This simplifies follow-up care in Australia. Many emphasise that dedicated visa and accommodation support makes the medical journey in India significantly easier.
Specialised Indian medical centres achieve cure rates between 80% and 90% for specific childhood cancers. The national average remains closer to 50–60%. However, high-volume facilities in major cities provide survival outcomes comparable to developed nations. Factors like early diagnosis and supportive care significantly improve these results.
Bookimed Expert Insight: A distinct pattern emerges among India's high-performing hospitals. Examples include Global Hospital Chennai and Aster CMI Hospital. These facilities often perform world-first or national-first complex paediatric surgeries. Choosing a centre with both JCI accreditation and a high volume of international cases typically correlates with better survival rates. For complex cases, these rates reach 70–75%.
Patient Consensus: Patients note that early detection is the biggest factor for success in India. Experience shows that metropolitan centres offer significantly better supportive care. This often includes infection control and nutrition, which helps children tolerate intensive treatment plans.
English is the primary language for paediatric oncology in India’s major tertiary hospitals. Specialists, nurses, and administrative staff in JCI-accredited centres communicate fluently in English. All medical documentation, treatment protocols, and pathology reports are in standard English. This ensures clinical accuracy.
Bookimed Expert Insight: While English is standard, high patient volumes mean consultations are often brief. Leading clinics like Global Hospital Chennai and Aster CMI Hospital include personal coordinators in their international packages. These coordinators bridge communication gaps during busy rounds. This helps Australian families understand every detail of the treatment plan.
Patient Consensus: Australian families find navigating care in India straightforward because medical teams speak excellent English. Patients note that coordinators at major urban centres handle all logistics. This makes the transition between diagnostics and surgery feel seamless.
India offers paediatric oncology at JCI-accredited facilities like Apollo Hospital Indraprastha and BLK Super Speciality Hospital. These centres provide specialised care for childhood leukaemia, neuroblastoma, and paediatric brain tumours. They employ multidisciplinary teams. They use precise technologies like CyberKnife and robotic surgery to protect healthy growing tissues.
Bookimed Expert Insight: Many centres treat childhood cancer. However, hospitals like BLK Super Speciality and Global Hospital Chennai stand out for their high-volume transplant units. BLK alone houses Asia's largest bone marrow transplant facility. These high-volume centres often have more experienced pathology labs and specialised paediatric nursing teams. These are vital for managing the intensive recovery phases of young patients.
Patient Consensus: Families note that Indian hospitals provide a child-friendly environment and comprehensive support. This includes help with visas and finding local accommodation. High-tech treatments like CyberKnife are available at much lower costs than in Australia. Patients frequently mention this.
Accommodation near Indian paediatric oncology centres is widely available but varies by type. Families often choose between hospital-affiliated guest houses, NGO-managed facilities like Access Life, and serviced apartments. Major hubs like Delhi, Mumbai, and Chennai offer diverse options for long-term stays during intensive treatment.
Bookimed Expert Insight: Quality clinics in Bengaluru and Gurgaon often bundle logistics into their service model. For instance, Aster CMI Hospital and Fortis Escorts provide free airport transfers and dedicated coordinators. These services are vital for Australian families. They eliminate the stress of navigating Indian traffic while managing a child's oncology appointments.
Patient Consensus: Patients note that staying within walking distance is vital for frequent chemotherapy visits. Families highlight that contacting the hospital first often reveals low-cost, on-site housing options in India.
Finding the best paediatric oncologist in India means choosing specialists at JCI-accredited centres. These centres have large bone marrow transplant units. Top hospitals in Delhi, Mumbai, and Bengaluru provide multidisciplinary teams and radiotherapy. They also offer specialised paediatric ICU support. This helps manage complex childhood cancers effectively.
Bookimed Expert Insight: India's highest-rated paediatric oncology centres often treat over 100 bone marrow transplant cases annually. Clinics with 1,000+ beds, like Global Hospital Chennai, typically offer on-site interpreters and airport transfers. This level of infrastructure suggests the hospital can manage multi-week inpatient stays. Such stays are common in paediatric care.
Patient Consensus: Patients seek hospitals in major cities like Mumbai or Delhi. This gives them access to molecular oncology. They note it's helpful to choose specialists with international affiliations. They also emphasise having a full multidisciplinary team available locally in India.
India provides intensive paediatric oncology treatments, including allogeneic and haploidentical bone marrow transplants (BMT) for leukaemia and genetic disorders. Facilities like BLK Super Speciality Hospital house Asia's largest BMT units. Centres use technologies, including CAR T-cell therapy, Da Vinci robotic surgery, and CyberKnife VSI systems.
Bookimed Expert Insight: India's largest centres, like Apollo Hospital Indraprastha, operate as massive transplant hubs. They often treat 1,000,000+ patients annually. This massive volume allows clinics to maintain on-site diagnostic labs. These labs provide faster results for critical bone marrow biopsies than smaller overseas facilities. This speed is vital for children needing immediate treatment adjustments.
Patient Consensus: Australian families note that India offers high success rates for paediatric BMT. Donors typically recover within 3–5 days after peripheral stem cell collection. Patients appreciate the shorter wait times and the availability of JCI-accredited hospitals. These hospitals provide a dedicated personal coordinator to help navigate the medical journey.
Major Indian tertiary hospitals provide specialised paediatric oncology services. These include dedicated wards, childhood cancer specialists, and holistic family support. Facilities like BLK Super Speciality Hospital house large bone marrow transplant units. JCI-accredited centres such as Artemis and Manipal Hospitals offer integrated care for complex paediatric malignancies.
Bookimed Expert Insight: Indian hospitals often operate a shared care model for paediatric cases. Major hubs like Apollo Hospital Indraprastha handle complex surgeries and transplants. Families then transition to regional centres for continuing chemotherapy. This network approach allows children to recover closer to home. Meanwhile, they access surgical expertise in metro cities.
Patient Consensus: Parents find that major Indian centres offer nearly free treatment for low-income families. They also offer residential support. Formal play therapy is less common. However, the focus on keeping families together during treatment is a significant emotional relief.
Follow-up care for paediatric cancer in India involves structured survivorship programs. These programs monitor for recurrence and manage late-term side effects. Major JCI-accredited centres provide multidisciplinary reviews, imaging scans, and specialised blood tests. Specialist monitoring often continues for 5 years after successful treatment to confirm complete recovery.
Bookimed Expert Insight: Many leading Indian hospitals, such as Global Hospital Chennai, maintain a 5-year discharge benchmark for paediatric cases. Once a child remains clear for 5 years, they are officially discharged as cured. This timeframe aligns with international standards. However, it often includes more frequent scans in the first 24 months.
Patient Consensus: Families in India value the compassionate post-treatment support. They note that following a strict scan schedule every 3 to 6 months is vital. Many suggest checking for government health schemes. These can help fund long-term monitoring through hospital radiotherapy departments.
Paediatric oncologists in India treat childhood blood cancers and solid tumours. Specialists manage acute lymphoblastic leukaemia (ALL), neuroblastoma, and Ewing sarcoma. Facilities like Artemis Hospitals and Manipal Hospitals use technologies including CyberKnife and robotic surgery. Treatments focus on high survival rates and long-term recovery.
Bookimed Expert Insight: Indian paediatric oncology centres prioritise multidisciplinary tumour boards for complex cases. Large medical networks, such as Apollo Hospital Indraprastha, treat over 1,000,000 patients annually. This massive volume allows specialists to refine protocols for rare conditions like neuroblastoma. Parents benefit from concentrated expertise often found only in major global research hubs.
Patient Consensus: Parents in India note that dedicated paediatric specialists outperform general oncologists. Families note that centres with high-risk protocols and multidisciplinary teams smooth the treatment process.
India lacks standalone hospitals exclusively for paediatric cancer. Instead, specialised care is provided through dedicated paediatric oncology wings within major cancer centres. These JCI-accredited facilities include Apollo Hospital Indraprastha and Manipal Hospitals. They feature multidisciplinary teams, advanced bone marrow transplant units, and specialised technologies for childhood tumours.
Bookimed Expert Insight: Patients often search for children-only buildings. However, the highest success rates in India are found in multi-specialty hubs. These centres, such as Global Hospital Chennai, perform 18,000+ operations annually. Their massive patient volume allows for niche specialisation in complex cases, such as multiple organ transplants in children weighing under 7 kg. Standalone clinics rarely manage such procedures.
Patient Consensus: Patients note that India uses an integrated model. However, the specialised wings feel separate and child-focused. Families appreciate the comprehensive support. This includes free interpreters, airport transfers, and help with visas during long treatment stays.